First manifestation of psoriasis vulgaris in tumor necrosis factor receptor-associated periodic syndrome during treatment with etanercept [Erstmanifestation einer psoriasis vulgaris bei tumornekrosefaktor-rezeptor- 1-assoziiertem periodischem syndrom unter therapie mit etanercept]

被引:0
作者
Boms S. [1 ,3 ]
Sehr T. [1 ]
Jappe U. [2 ]
Enk A. [1 ]
机构
[1] Paul-Ehrlich-Institut, Langen
[2] Universitäts-Hautklinik, Ruprecht-Karls Universität Heidelberg, 69115 Heidelberg
来源
Der Hautarzt | 2008年 / 59卷 / 8期
关键词
Etanercept; Hereditary periodic fever syndrome; Psoriasis; TRAPS; Tumour necrosis factor receptor;
D O I
10.1007/s00105-007-1451-5
中图分类号
学科分类号
摘要
Drugs antagonizing tumor necrosis factor (TNF) α have been increasingly and successfully used in the treatment of psoriasis vulgaris and psoriatic arthritis. We report a patient with TNF receptor 1-associated periodic syndrome (TRAPS) who received TNF-α antagonist etanercept. A month later, the patient developed for the first time generalized psoriasis vulgaris. This paradoxical phenomenon has been reported sporadically in patients receiving TNF-α antagonists for other inflammatory diseases. The cause of psoriasis induced by TNF-α antagonists is still obscure. © 2008 Springer Medizin Verlag.
引用
收藏
页码:653 / 655
页数:2
相关论文
共 13 条
  • [1] Bhatia, J Rheumatol, 34, (2007)
  • [2] Church, Springer Semin Immunopathol, 27, (2006)
  • [3] Dutz, J Rheumatol, 34, (2007)
  • [4] Gannes, Arch Dermatol, 143, (2007)
  • [5] Hull, Medicine, 81, (2002)
  • [6] Kary, Ann Rheum Dis, 65, (2006)
  • [7] Mease, Ann Rheum Dis, 63, (2004)
  • [8] Nowlan, Rheumatology, 45, (2006)
  • [9] Pirard, Dermatology, 213, (2006)
  • [10] Reimold, Am J Med Sci, 325, (2003)